Good points. A system with universal private health insurance and pharma companies that reinvest all their profits into research seems equivalent to a system with publicly funded research. (Of course, in private systems there are many uninsured people -- doubling the price of cancer treatments means, to some extent, funding future research from poor, sick people.)